These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

807 related items for PubMed ID: 19438435

  • 21. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
    Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH.
    Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
    [Abstract] [Full Text] [Related]

  • 22. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
    Yu J, Henske EP.
    Cancer Res; 2006 Oct 01; 66(19):9461-6. PubMed ID: 17018601
    [Abstract] [Full Text] [Related]

  • 23. Refeeding and insulin activate the AKT/p70S6 kinase pathway without affecting IRS1 tyrosine phosphorylation in chicken muscle.
    Duchêne S, Métayer S, Audouin E, Bigot K, Dupont J, Tesseraud S.
    Domest Anim Endocrinol; 2008 Jan 01; 34(1):1-13. PubMed ID: 17029674
    [Abstract] [Full Text] [Related]

  • 24. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P, Mateo J.
    Oncogene; 2009 Jan 22; 28(3):313-24. PubMed ID: 18978810
    [Abstract] [Full Text] [Related]

  • 25. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
    Wlodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES, Slupianek A, Wasik MA.
    Cancer Res; 2005 Sep 01; 65(17):7800-8. PubMed ID: 16140948
    [Abstract] [Full Text] [Related]

  • 26. Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation.
    Gerasimovskaya EV, Tucker DA, Stenmark KR.
    J Appl Physiol (1985); 2005 Feb 01; 98(2):722-31. PubMed ID: 15501927
    [Abstract] [Full Text] [Related]

  • 27. Activation of the Akt/mammalian target of rapamycin pathway in myxofibrosarcomas.
    Takahashi Y, Kohashi K, Yamada Y, Endo M, Setsu N, Ishii T, Yamamoto H, Iwamoto Y, Oda Y.
    Hum Pathol; 2014 May 01; 45(5):984-93. PubMed ID: 24746202
    [Abstract] [Full Text] [Related]

  • 28. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).
    Evren S, Dermen A, Lockwood G, Fleshner N, Sweet J.
    Prostate; 2010 Sep 15; 70(13):1429-36. PubMed ID: 20687216
    [Abstract] [Full Text] [Related]

  • 29. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S, Khuri FR, Roman J.
    Cancer Res; 2006 Jan 01; 66(1):315-23. PubMed ID: 16397245
    [Abstract] [Full Text] [Related]

  • 30. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease.
    Chen SY, Moroi Y, Urabe K, Takeuchi S, Kido M, Hayashida S, Uchi H, Uenotsuchi T, Tu YT, Furue M.
    Arch Dermatol Res; 2008 Apr 01; 300(4):195-201. PubMed ID: 18210145
    [Abstract] [Full Text] [Related]

  • 31. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y, Chen SY, Ross KN, Balk SP.
    Cancer Res; 2006 Aug 01; 66(15):7783-92. PubMed ID: 16885382
    [Abstract] [Full Text] [Related]

  • 32. Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
    Grozinsky-Glasberg S, Franchi G, Teng M, Leontiou CA, Ribeiro de Oliveira A, Dalino P, Salahuddin N, Korbonits M, Grossman AB.
    Neuroendocrinology; 2008 Aug 01; 87(3):168-81. PubMed ID: 18025810
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, Roth RA, Hidalgo M.
    Clin Cancer Res; 2004 Dec 01; 10(23):8059-67. PubMed ID: 15585641
    [Abstract] [Full Text] [Related]

  • 34. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex.
    Sui L, Wang J, Li BM.
    Learn Mem; 2008 Oct 01; 15(10):762-76. PubMed ID: 18832563
    [Abstract] [Full Text] [Related]

  • 35. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
    Kristof AS, Pacheco-Rodriguez G, Schremmer B, Moss J.
    J Pharmacol Exp Ther; 2005 Sep 01; 314(3):1134-43. PubMed ID: 15923340
    [Abstract] [Full Text] [Related]

  • 36. Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation.
    Riera MF, Regueira M, Galardo MN, Pellizzari EH, Meroni SB, Cigorraga SB.
    Am J Physiol Endocrinol Metab; 2012 Apr 15; 302(8):E914-23. PubMed ID: 22275758
    [Abstract] [Full Text] [Related]

  • 37. Forskolin attenuates the action of insulin on the Akt-mTOR pathway in human skeletal muscle.
    Richmond SR, Touchberry CD, Gallagher PM.
    Appl Physiol Nutr Metab; 2009 Oct 15; 34(5):916-25. PubMed ID: 19935854
    [Abstract] [Full Text] [Related]

  • 38. Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma.
    Li W, Tan D, Zhang Z, Liang JJ, Brown RE.
    Oncol Rep; 2008 Oct 15; 20(4):713-9. PubMed ID: 18813808
    [Abstract] [Full Text] [Related]

  • 39. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.
    Wang W, Wen Q, Xu L, Xie G, Li J, Luo J, Chu S, Shi L, Huang D, Li J, Fan S.
    PLoS One; 2014 Oct 15; 9(8):e106098. PubMed ID: 25165983
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.